site stats

Evotec offers to acquire cyprotex

WebDec 15, 2016 · Acquisition of 100% shares in Cyprotex PLC effective 14 December 2016; Evotec is paying £ 55.7 m in cash for the full share capital of Cyprotex and funding of … WebOct 26, 2016 · Evotec AG today announced that it has made an offer to acquire Cyprotex PLC , a specialist... January 20, 2024

Evotec Plans to Acquire Cyprotex Technology Networks

WebOct 27, 2016 · German drug discovery company Evotec announced Wednesday that it agreed to acquire contract research organization Cyprotex for €62 million ($67.7 million). The deal is the latest in a string of recent acquisitions for Evotec. The company bought another CRO, Euprotec Ltd., in May 2014 for $2.3 million upfront. lama permainan bola basket mini https://daniutou.com

Evotec to acquire Cyprotex S&P Global Market Intelligence

WebOct 26, 2016 · - Acquisition would add world-leading high-quality ADME-Tox services and strengthen Evotec's leadership in drug discovery - Evotec will pay approximately £ 55.36 m in... April 9, 2024 WebOct 26, 2016 · HAMBURG, Germany--(BUSINESS WIRE)--Evotec AG (Frankfurt Stock Exchange, Prime Standard, ISIN: DE 000 566480 9, WKN 566480) today announced that it has made an offer to acquire Cyprotex PLC (AIM Listing: CRX-GB), a specialist pre-clinical contract research organisation in ADME-Tox and DMPK headquartered in … WebAcquisition would add world-leading high-quality ADME-Tox services and strengthen Evotec's leadership in drug discovery Evotec will pay approximately £ 55.36 m (EUR 62.00 m) in cash for the full share capital of Cyprotex and funding of all existing debt of the AIM-listed company Proposed acquisition, unanimously recommended by the board jeran plumacher

EVOTEC ANNOUNCES ITS INTENT TO ACQUIRE CYPROTEX PLC

Category:Evotec announces its intent to acquire Cyprotex PLC

Tags:Evotec offers to acquire cyprotex

Evotec offers to acquire cyprotex

BRIEF-Evotec plans to acquire Cyprotex for 62 mln eur Reuters

WebOct 26, 2016 · The offer of 1.60 £ per Cyprotex share reflects a 9.4% premium to the VWAP of the past 30 trading days at AIM. The offer is intended to be implemented by a scheme of arrangement regulated by the UK takeover code, with already >50% shares secured irrevocable. The acquisition will add to Evotec’s revenues and be accretive to … WebOct 26, 2016 · * Evotec AG announces its intent to acquire Cyprotex plc * Offer is intended to be implemented by a scheme of arrangement regulated by uk takeover code, with already >50% shares secured irrevocable

Evotec offers to acquire cyprotex

Did you know?

WebOct 27, 2016 · German biotech firm Evotec has made an offer to acquire UK-based Cyprotex, a specialist pre-clinical… To continue reading The Pharma Letter please login … WebOct 26, 2016 · DGAP-News: Evotec AG / Key word(s): Mergers & Acquisitions2016-10-26 / 09:12The issuer is solely responsible for the content of this announcement.----- Acquisition would add world-leading high-quality ADME-Tox services andstrengthen Evotec's leadership in drug discovery- Evotec will pay approximately £ 55.36 m (EUR 62. ...

WebOct 25, 2016 · HAMBURG, Germany--(BUSINESS WIRE)--Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced that it has made an … WebOct 26, 2016 · The offer of 1.60 £ per Cyprotex share reflects a 9.4% premium to the VWAP of the past 30 trading days at AIM. The offer is intended to be implemented by a scheme of arrangement regulated by the UK takeover code, with already >50% shares secured irrevocable. The acquisition will add to Evotec’s revenues and be accretive to …

WebFeb 15, 2024 · Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that Cyprotex US, LLC, the US site of Cyprotex a wholly owned subsidiary of Evotec, has completed its relocation from Watertown, MA to a new state-of-the-art facility in Framingham, MA, paving the way for … WebCyprotex’s customers will now be able to access Evotec’s integrated and standalone drug discovery services and the acquisition expands Cyprotex’s service portfolio to include medicinal chemistry, structural biology and in vitro and in vivo pharmacology services. Evotec can also offer specialist expertise in key therapeutic areas such as ...

WebOct 26, 2016 · Evotec said today it has offered to acquire Cyprotex for £55.36 million ($67.6 million) in a deal designed to strengthen the buyer’s drug discovery efforts. …

WebOct 27, 2016 · The offer of 1.60 £ per Cyprotex share reflects a 9.4% premium to the VWAP of the past 30 trading days at AIM. The offer is intended to be implemented by a … lama permainan bola kastiWebOct 27, 2016 · Evotec AG announced that it has made an offer to acquire Cyprotex PLC, a specialist pre-clinical contract research organisation in ADME-Tox and DMPK. Cyprotex serves the industry's increasing requ ... jera norse runeWebFeb 15, 2024 · Further, Cyprotex’ customers and partners will stand to benefit from additional specialist services e.g. a full suite of transporter assays and a high-throughput transcriptomics offering for predicting drug-induced toxicity, which Cyprotex performs together with its parent company Evotec. With 30,000 square feet, Cyprotex’ new … lama permainan bola basket adalahWebApr 29, 2024 · The Story of Cyprotex – 20 Years of Excellence. Posted 29th April 2024 by Cyprotex. It’s been quite a journey over the past 20 years! In this blog, we travel down memory lane as we track how Cyprotex has grown to become one of world’s most well recognised and trusted ADME-Tox providers. The story begins in April 1999 when … jerantinine eWebDec 14, 2016 · Evotec AG reached an agreement on the terms of the offer to acquire Cyprotex plc from Trident Private Equity Fund III LP managed by Harwood Private Equity, Oryx ... lama permainan basketWebOct 26, 2016 · Evotec will pay approximately £ 55.36 m (EUR 62.00 m; £/EUR exchange rate of 1.12) in cash for the acquisition of all 26.1 million issued and to be issued Cyprotex shares and the funding of all ... jerantiWebOct 26, 2016 · * Evotec AG announces its intent to acquire Cyprotex plc * Offer is intended to be implemented by a scheme of arrangement regulated by uk takeover code, … jeranosjan